Conference
Final results of a phase I study of the Raf-1 kinase inhibitor BAY 43-9006 in patients with advanced refractory solid tumours
Authors
Hirte H; Moore M; Hotte S; Oza A; Siu L; Harris H; MacLean M; Petrenciuc O; Fiander W; Lathia C
Volume
38
Pagination
pp. S55-S55
Publisher
PERGAMON-ELSEVIER SCIENCE LTD
Publication Date
November 1, 2002
Name of conference
14th EORTC/NCI/AACR Symposium on Molecular Targets and Cancer Therapeutics
Conference place
FRANKFURT, GERMANY
Conference start date
November 19, 2002
Conference end date
November 22, 2002
Conference proceedings
EUROPEAN JOURNAL OF CANCER
ISSN
0959-8049